GIDARA Energy is excited to announce the acquisition of a crucial environmental permit for its ground breaking Advanced Methanol Amsterdam (AMA) facility. Click to read more.
hVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed to treat seasonal flu.
hVIVO is a London-based specialist. | April 3, 2023
SAN DIEGO, March 31, 2023 Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases,. | March 31, 2023
By Josh Beckerman Cidara Therapeutics Inc. shares fell 3% to $1.84 in late trading after it said the Food and Drug Administration approved Rezzayo, or rezafungin for injection. The drug. | March 23, 2023